Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Globally, 3.5-6% of the human population is affected by rare diseases, corresponding to 260-450 million people worldwide. If we consider that the impact extends to family members and caregivers, rare diseases affect over 1 billion people worldwide. Rare diseases have serious social, health, and economic impacts for affected families. These difficulties stem not only from the disabilities arising from rare diseases, but also from trouble in receiving definitive diagnoses, and a lack of treatment options. The genomic revolution over the past 2 decades has led to significant advances in rare disease research as well as the establishment of nationwide projects aiming to integrate genomics into mainstream healthcare.
This Collection will feature high-impact papers on the application of genomics to tackle rare diseases. We welcome submissions on topics including (but not limited to):
Integrative phenotype and genome data analysis to tackle the diagnostic/treatment challenges of rare diseases
Innovative technologies and strategies to tackle rare diseases as a healthcare priority
Description of novel genetic syndromes and their underlying disease mechanisms
Large-scale studies providing new insight in rare disease diagnosis, disease mechanism, and treatment strategies
The phenotypic spectrum of rare diseases in different ancestry groups across the world
Case reports that present phenotypic information without any genetic/genomic findings that provide new insights shall not be considered.
This Collection supports and amplifies research related to SDG 3.